Tetra's pre-clinical studies have demonstrated that ARDS-003 decreases this hyperinflammatory response and slows disease progression. While the clinical profile of ARDS arising from viral (COVID) or bacterial sepsis can vary, hyperinflammation involving a dysfunctional immune response is a common mediator of lung damage. GENERAL INFORMATION Product Name (4-Chlorophenyl)-2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside. Tetra Bio-Pharma is focused on drug development programs in Inflammation, Pain, Ophthalmology and Oncology, aimed at bringing novel drugs and treatments to patients and their healthcare providers. ARDS-003 is positioned to modulate acute systemic inflammation and prevent sepsis, ARDS, and organ damage. Buy (4-Chlorophenyl)-2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside from Smolecule. Stay tuned for updates!įor more details, here's today's press release: ĪRDS-003 is a novel First in Human (FIH) drug product containing the active pharmaceutical agent, Onternabez, a potent and selective full agonist of the type 2 cannabinoid receptor (CB2R), an essential immunomodulatory target. We look forward to sharing our discoveries with the scientific community and the public. We extend our gratitude to the National Research Council Canada / Conseil national de recherches Canada for recognizing the value of our research and for their support which will allow us to bring our work to the next level. For all inquiries, contact Tetra Bio-Pharma at: 1 (833) 977-7575 (toll-free) 1 (438) 899-7575 (Quebec) 1 (343) 780 2020 (Ontario) Head office address 2316 St-Joseph Blvd. Get the latest Tetra Bio Pharma Inc (TBPMF) real-time quote, historical performance, charts, and other financial information to help you make more informed. □□□ □□□□! Tetra is receiving funding from the Government of #Canada to explore revolutionary #research in acute systemic hyperinflammation with its #ARDS-003 oral formulation.
0 Comments
Leave a Reply. |